# Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/characterization-of-acne-associated-with-upadacitinib-treatment-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Pedro Mendes‐Bastos,Barry Ladizinski,Emma Guttman‐Yassky,Ping Jiang,John Liu,Vimal H. Prajapati,Eric L. Simpson,Namita Vigna,Henrique D. Teixeira,S. Barbarot |
| Citations | 64 |
| DOI | 10.1016/j.jaad.2022.06.012 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.jaad.2022.06.012 |
| OpenAlex ID | https://openalex.org/W4282942340 |
| PMID | 35714786 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Pedro Mendes‐Bastos](https://scholariq.org/researchers/pedro-mendes-bastos/)

## Paper primary topic

- [Acne and Rosacea Treatments and Effects](https://scholariq.org/topics/acne-and-rosacea-treatments-and-effects/)

## Paper topics

- [Acne and Rosacea Treatments and Effects](https://scholariq.org/topics/acne-and-rosacea-treatments-and-effects/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Hidradenitis Suppurativa and Treatments](https://scholariq.org/topics/hidradenitis-suppurativa-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.